Periodic Reporting for period 2 - eCHO Systems (Enhancing CHO by Mammalian Systems Biotechnology (eCHO systems))

Summary
Chinese hamster (CHO) ovary cells are the production host for a +50 billion €/yr biopharmaceuticals market. Current CHO production platforms dates to 1980 and are based primarily on media and process optimisation with little consideration to the optimization of the cellular...
More information & hyperlinks